Antarctic Fish Show Widespread Gene Loss Adapted to Extreme Cold
Researchers analyzing Antarctic notothenioid fish genomes identified 30 genes that have been lost across the entire clade and 12 additional genes lost specifically in icefishes, representing a natural experiment in gene loss under extreme environmental conditions. These losses affect genes involved in lipid metabolism, oxygen transport, skeletal mineralization, and other functions, yet the fish remain viable in their stable polar environment. The findings suggest that Antarctic notothenioids serve as a natural model for understanding how loss-of-function genetic variants can persist in wild populations and how organisms adapt to chronic cold.
A comparative genomic study of Antarctic notothenioid fishes revealed systematic gene loss across the clade following its diversification in the thermally stable Southern Ocean. Using whole-genome alignments across 11 Antarctic species and four non-Antarctic outgroups, researchers identified 30 high-confidence gene losses shared across all sampled cryonotothenioids, affecting pathways related to lipid and amino acid metabolism, water transport, glucose reabsorption, skeletal mineralization, circadian regulation, and tRNA modification. An additional 12 genes were lost specifically in icefishes but retained in red-blooded notothenioids, including genes associated with oxygen transport and iron handling. The researchers applied stringent filtering to exclude assembly artifacts and genes with detectable transcriptomic support, ensuring high confidence in their findings. Many of these lost genes are conserved across vertebrates and associated with disease phenotypes in humans, making Antarctic notothenioids valuable for studying how organisms compensate for gene loss through paralog compensation and pathway rewiring under chronic environmental stress.
Limitations & open questions
The study does not discuss potential limitations in detecting gene loss from genomic assemblies (e.g., whether pseudogenized or highly diverged sequences might be missed), the specific mechanisms by which these losses are tolerated (paralog compensation, pathway redundancy, or environmental buffering), or whether similar patterns of gene loss occur in other cold-adapted vertebrate lineages for comparison.
What different sources said
- bioRxivCenter
Gene loss under constant cold reveals "natural knockout" loci in Antarctic notothenioid fishes
Related
Computational Study Identifies Plant-Derived Peptide as Potential MDM2-p53 Inhibitor
Researchers used computational screening of plant proteomes to identify SPAFESTWDILK, a 12-amino-acid peptide from ginger, as a predicted binder to MDM2—a protein that regulates the tumor suppressor p53. The discovery employed multiple computational methods including AlphaFold 3 co-folding and molecular dynamics simulations, with results showing consistent binding predictions across eight different assessments. The finding is significant because no food-derived linear peptide has previously been documented to engage the MDM2-p53 interface, though the authors acknowledge that experimental validation is needed.
Active Learning Framework Guides Design of Peptides to Modulate Biomolecular Condensate Properties
Researchers used active learning combined with molecular dynamics simulations to design peptide variants that can tune the physical properties of biomolecular condensates, specifically studying the MUT-16 condensate in C. elegans. The approach integrates Bayesian optimization with neural networks to efficiently identify peptide sequences that modulate condensate behavior while reducing computational requirements. This work could enable rational engineering of synthetic condensates and inform therapeutic strategies for diseases linked to condensate dysfunction, including neurodegenerative disorders.
Researchers Develop 'Molecular Eraser' to Destroy Cancer-Causing mRNA Before Protein Forms
Scientists at the Max Planck Institute have created a new therapeutic approach that targets and destroys mRNA of the NRAS cancer protein before it can be translated into protein. RAS mutations are responsible for many of the deadliest cancers, but effective treatments have remained elusive. This mRNA-targeting strategy could represent a new avenue for treating previously difficult-to-address cancers.